0001654954-24-007462.txt : 20240606
0001654954-24-007462.hdr.sgml : 20240606
20240606182756
ACCESSION NUMBER: 0001654954-24-007462
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240605
FILED AS OF DATE: 20240606
DATE AS OF CHANGE: 20240606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cornell Alison A
CENTRAL INDEX KEY: 0001549395
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40449
FILM NUMBER: 241026703
MAIL ADDRESS:
STREET 1: 210 CARNEGIE CENTER
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zivo Bioscience, Inc.
CENTRAL INDEX KEY: 0001101026
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 870699977
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 E. LONG LAKE ROAD
STREET 2: SUITE 100
CITY: BLOOMFIELD HILLS
STATE: MI
ZIP: 48304
BUSINESS PHONE: (248) 452 9866
MAIL ADDRESS:
STREET 1: 21 E. LONG LAKE ROAD
STREET 2: SUITE 100
CITY: BLOOMFIELD HILLS
STATE: MI
ZIP: 48304
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTH ENHANCEMENT PRODUCTS INC
DATE OF NAME CHANGE: 20040202
FORMER COMPANY:
FORMER CONFORMED NAME: WESTERN GLORY HOLE INC
DATE OF NAME CHANGE: 19991215
4
1
section16.xml
FORM 4
X0508
4
2024-06-05
0001101026
Zivo Bioscience, Inc.
ZIVO
0001549395
Cornell Alison A
362 MORNING GLORY LANE
MARCO ISLAND
FL
34145
true
false
false
false
Common Stock
2024-06-05
4
A
false
60724
A
144578
D
Common Stock
2024-06-05
4
A
false
95134
7.96
A
239712
D
Nonstatutory Stock Option to Purchase Common Stock
26.88
2024-06-05
4
D
false
3179
D
2031-10-11
Common Stock
3179
0
D
Nonstatutory Stock Option to Purchase Common Stock
21.66
2024-06-05
4
D
false
2632
D
2032-07-27
Common Stock
2632
0
D
Nonstatutory Stock Option to Purchase Common Stock
17.16
2024-06-05
4
D
false
707
D
2032-12-15
Common Stock
707
0
D
Nonstatutory Stock Option to Purchase Common Stock
15.66
2024-06-05
4
D
false
23240
D
2032-12-18
Common Stock
23240
0
D
Nonstatutory Stock Option to Purchase Common Stock
16.74
2024-06-05
4
D
false
3626
D
2033-06-11
Common Stock
3626
0
D
The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023.
The canceled options were fully vested.
The Issuer canceled options for an aggregate 33,384 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 7/28/2022, 12/16/2022, 12/19/2022, and 6/12/2023. In exchange for the canceled options, the Reporting Person received 60,724 shares of restricted stock.
The canceled option was issued pursuant to the 2021 Equity Incentive Plan on 6/12/2023 and vested as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2024 Annual Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date.
/s/ Alison Cornell
2024-06-06